Destination NSW announces new marketing lead mumbrella.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mumbrella.com.au Daily Mail and Mail on Sunday newspapers.
Aussie dollar tipped to weaken and this ASX share stands to gain the most
Brendon Lau | April 8, 2021 12:36pm |
More on: Image source: Getty Images
The golden run in the Australian dollar may be over and that could have implications for a number of ASX shares.
The Aussie crashed to around US57 cents during the height of the COVID-19 mayhem in March 2020 but came roaring back.
It peaked at just under US80 cents in February this year before easing back to just over US76 cents.
Australian dollar past its prime
The Aussie battler is unlikely to be testing new highs anytime soon. It’s even tipped to weaken further, according to JPMorgan.
Active Implantable Medical Devices Market Size Estimated to Reach $27 7 Billion by 2025 briefingwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from briefingwire.com Daily Mail and Mail on Sunday newspapers.
3 outstanding ASX shares to buy and hold
James Mickleboro | April 2, 2021 11:42am |
More on: Image source: Getty Images
If you’re looking for shares to buy and hold, then the three listed below could be quality options.
All three have long runways for growth and could provide strong returns for investors if everything goes to plan. Here’s what you need to know:
The first ASX share to consider as a buy and hold investment is Cochlear. It is a global developer, manufacturer, and distributor of cochlear implantable devices for the hearing impaired. It appears well-placed for long term growth thanks to its exposure to the ageing population tailwind. This is because as people age their hearing will more often than not fade. This is expected to lead to increasing demand for its industry-leading products over the next couple of decades. Macquarie currently has an outperform rating and $245.00 price target.
12 Mar 2021
NSW Minister for Jobs, Investment, Tourism and Western Sydney Stuart Ayres has announced the appointment of Christine McLoughlin as the new chair of the state’s destination marketing agency.
McLoughlin (pictured above) is one of Australia’s most highly-regarded company directors and an accomplished business leader, having held various domestic and international executive positions in a range of industries spanning the corporate, government and not-for-profit spheres.
She is currently chair of Suncorp Group, chancellor of the University of Wollongong, and a director for Venues NSW, Cochlear Limited and the McGrath Foundation. McLoughlin is also the co-founder and chair of the Minerva Network